InvestorsHub Logo
Followers 10
Posts 778
Boards Moderated 0
Alias Born 03/18/2003

Re: WolfofMia post# 347995

Tuesday, 02/01/2022 1:58:42 PM

Tuesday, February 01, 2022 1:58:42 PM

Post# of 458032

Nothing here is screwed up if the FDA is the one recommending the changes.

Lying or not, I don't know. But if the FDA did in fact make these recommendations, it is a game changer. Given this from the PR,

“This is now the second successful placebo-controlled study of ANAVEX®2-73 in adult patients with Rett syndrome, and this Phase 3 study builds on the platform potential of ANAVEX®2-73 and its ability to demonstrate clinically meaningful improvements in Rett syndrome symptoms in the ANAVEX®2-73 treatment group compared to placebo,”

it may imply the FDA is coming around to the "platform potential" mentioned above.

IMHO
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News